Alk Sustainability Profile
Alk, officially known as Alk Abello A/S, is a leading player in the biopharmaceutical industry, headquartered in Denmark (DK). Founded in 1923, the company has established itself as a pioneer in allergy immunotherapy, focusing on innovative treatments for allergic conditions. With a strong presence in Europe and North America, Alk is dedicated to improving the quality of life for allergy sufferers through its advanced products. The company’s core offerings include sublingual and injectable immunotherapy solutions, which are distinguished by their efficacy and patient-friendly administration methods. Alk's commitment to research and development has positioned it as a market leader, achieving significant milestones such as the introduction of the first sublingual tablet for grass pollen allergy. With a robust portfolio and a focus on patient-centric solutions, Alk continues to drive advancements in allergy treatment.
DitchCarbon Score
How does Alk's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Alk's score of 50 is higher than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Alk's reported carbon emissions
In 2023, ALK-Abelló A/S reported total greenhouse gas emissions of approximately 69,555,000 kg CO2e. This figure includes Scope 1 emissions of about 5,128,000 kg CO2e, which comprise mobile combustion (1,454,000 kg CO2e) and fugitive emissions (501,000 kg CO2e). Scope 2 emissions totalled around 3,600,000 kg CO2e (market-based), while Scope 3 emissions were significant at approximately 64,067,000 kg CO2e, with major contributions from purchased goods and services (41,175,000 kg CO2e) and employee commuting (6,153,000 kg CO2e). ALK has made notable strides in reducing its carbon footprint, achieving a 41% reduction in absolute Scope 1 and 2 emissions from a 2019 baseline by 2022. Looking ahead, the company has committed to further reductions, targeting a 42% decrease in absolute Scope 1 and 2 emissions by 2030, using 2022 as the base year. Additionally, ALK aims for 80% of its suppliers to establish science-based targets by 2028, covering emissions from various categories including purchased goods and services, capital goods, and transportation. The emissions data and reduction targets are sourced directly from ALK-Abelló A/S, with no data cascaded from a parent or related organization. The company's commitments align with industry standards for climate action, reflecting a proactive approach to sustainability in the pharmaceuticals and biotechnology sector.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 5,479,000 | 0,000,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 2 | 3,003,000 | 0,000,000 | 0,000,000 | 000,000 | 000,000 |
| Scope 3 | 4,244,000 | 000,000 | 000,000 | 00,000,000 | 00,000,000 |
How Carbon Intensive is Alk's Industry?
How Carbon Intensive is Alk's Location?
Alk's Scope 3 Categories Breakdown
Alk's Scope 3 emissions, which decreased by 9% last year and increased significantly since 2019, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 64% of Scope 3 emissions.
Top Scope 3 Categories
Alk's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Alk has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
Frequently Asked Questions
Common questions about Alk's sustainability data and climate commitments